Bevacizumab, Vitrectomy, and Vitreous Hemorrhage

被引：2
作者：
Ahmadieh, Hamid [1 ]
Shoeibi, Nasser [2 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Labbafinejad Med Ctr, Tehran, Iran
[2] Mashhad Univ Med Sci, Khatam Al Anbia Hosp, Eye Res Ctr, Mashhad, Iran
来源：
OPHTHALMOLOGY | 2013年 / 120卷 / 01期
关键词：
PROLIFERATIVE DIABETIC-RETINOPATHY; INTRAVITREAL BEVACIZUMAB;
D O I：
10.1016/j.ophtha.2012.07.022
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：219 / 220
页数：4
相关论文
共 3 条
  • [1] Intravitreal Bevacizumab for Prevention of Early Postvitrectomy Hemorrhage in Diabetic Patients A Randomized Clinical Trial
    Ahmadieh, Hamid
    Shoeibi, Nasser
    Entezari, Morteza
    Monshizadeh, Ramin
    [J]. OPHTHALMOLOGY, 2009, 116 (10) : 1943 - 1948
  • [2] The Effect of Adjunctive Intravitreal Bevacizumab for Preventing Postvitrectomy Hemorrhage in Proliferative Diabetic Retinopathy
    Ahn, Jeeyun
    Woo, Se Joon
    Chung, Hum
    Park, Kyu Hyung
    [J]. OPHTHALMOLOGY, 2011, 118 (11) : 2218 - 2226
  • [3] Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)
    Rizzo, Stanislao
    Genovesi-Ebert, Federica
    Di Bartolo, Emanuele
    Vento, Andrea
    Miniaci, Sofia
    Williams, George
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (06) : 837 - 842
1